11/19
10:54 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/14
09:09 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
11/14
09:09 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
11/11
10:55 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
11/11
10:55 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
11/8
07:29 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
11/8
07:29 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/11
12:25 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/11
12:25 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/10
11:01 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.
Low
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.
10/10
11:01 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.
Low
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.
10/8
02:34 pm
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $44.00 price target on the stock.
Low
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $44.00 price target on the stock.
10/8
01:48 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/8
01:48 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/4
11:06 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
10/4
11:06 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
9/20
12:20 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
9/17
11:04 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $64.00 price target on the stock.
Low
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $64.00 price target on the stock.
9/17
10:35 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
9/4
08:06 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $44.00 price target on the stock.
Low
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $44.00 price target on the stock.
9/4
05:38 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
9/4
05:38 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
8/26
09:02 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $47.00 price target on the stock.
Low
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $47.00 price target on the stock.
8/26
08:17 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT